These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26198245)

  • 21. Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.
    Eng QY; Thanikachalam PV; Ramamurthy S
    J Ethnopharmacol; 2018 Jan; 210():296-310. PubMed ID: 28864169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
    Ahmad N; Gupta S; Mukhtar H
    Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Green tea epigallocatechin gallate inhibits insulin stimulation of adipocyte glucose uptake via the 67-kilodalton laminin receptor and AMP-activated protein kinase pathways.
    Hsieh CF; Tsuei YW; Liu CW; Kao CC; Shih LJ; Ho LT; Wu LY; Wu CP; Tsai PH; Chang HH; Ku HC; Kao YH
    Planta Med; 2010 Oct; 76(15):1694-8. PubMed ID: 20455202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Green Tea (-)-Epigallocatechin-3-Gallate (EGCG) on Cardiac Function - A Review of the Therapeutic Mechanism and Potentials.
    Li Y; Karim MR; Wang B; Peng J
    Mini Rev Med Chem; 2022; 22(18):2371-2382. PubMed ID: 35345998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
    Chen N; Bezzina R; Hinch E; Lewandowski PA; Cameron-Smith D; Mathai ML; Jois M; Sinclair AJ; Begg DP; Wark JD; Weisinger HS; Weisinger RS
    Nutr Res; 2009 Nov; 29(11):784-93. PubMed ID: 19932867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.
    Lambert JD; Sang S; Hong J; Kwon SJ; Lee MJ; Ho CT; Yang CS
    Drug Metab Dispos; 2006 Dec; 34(12):2111-6. PubMed ID: 16997910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
    Weber C; Sliva K; von Rhein C; Kümmerer BM; Schnierle BS
    Antiviral Res; 2015 Jan; 113():1-3. PubMed ID: 25446334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
    Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
    Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption, metabolism and antioxidative effects of tea catechin in humans.
    Miyazawa T
    Biofactors; 2000; 13(1-4):55-9. PubMed ID: 11237200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide.
    López-Lázaro M; Calderón-Montaño JM; Burgos-Morón E; Austin CA
    Mutagenesis; 2011 Jul; 26(4):489-98. PubMed ID: 21382914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.
    Zaveri NT
    Life Sci; 2006 Mar; 78(18):2073-80. PubMed ID: 16445946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
    Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
    Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice.
    Grove KA; Sae-tan S; Kennett MJ; Lambert JD
    Obesity (Silver Spring); 2012 Nov; 20(11):2311-3. PubMed ID: 21633405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells.
    Singh AK; Seth P; Anthony P; Husain MM; Madhavan S; Mukhtar H; Maheshwari RK
    Arch Biochem Biophys; 2002 May; 401(1):29-37. PubMed ID: 12054484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of gallate and pyrogallol moieties on the intestinal absorption of (-)-epicatechin and (-)-epicatechin gallate.
    Tagashira T; Choshi T; Hibino S; Kamishikiryou J; Sugihara N
    J Food Sci; 2012 Oct; 77(10):H208-15. PubMed ID: 22938538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: novel insights into therapeutic effects beyond its antioxidant and anti-inflammatory properties.
    Ntamo Y; Jack B; Ziqubu K; Mazibuko-Mbeje SE; Nkambule BB; Nyambuya TM; Mabhida SE; Hanser S; Orlando P; Tiano L; Dludla PV
    Crit Rev Food Sci Nutr; 2024; 64(1):87-109. PubMed ID: 35916835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.